These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 27550953)
1. A Phase II Randomized, Double-Blind, Placebo-Controlled Safety and Efficacy Study of Lenalidomide in Lumbar Radicular Pain with a Long-Term Open-Label Extension Phase. Manning DC; Gimbel J; Wertz R; Rauck R; Cooper A; Zeldis JB; Levinsky DM Pain Med; 2017 Mar; 18(3):477-487. PubMed ID: 27550953 [TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, placebo-controlled trial and open-label extension study to evaluate the efficacy and safety of pregabalin in the treatment of neuropathic pain associated with human immunodeficiency virus neuropathy. Simpson DM; Rice AS; Emir B; Landen J; Semel D; Chew ML; Sporn J Pain; 2014 Oct; 155(10):1943-54. PubMed ID: 24907403 [TBL] [Abstract][Full Text] [Related]
3. A randomized, placebo-controlled trial of the analgesic efficacy and safety of the p38 MAP kinase inhibitor, losmapimod, in patients with neuropathic pain from lumbosacral radiculopathy. Ostenfeld T; Krishen A; Lai RY; Bullman J; Green J; Anand P; Scholz J; Kelly M Clin J Pain; 2015 Apr; 31(4):283-93. PubMed ID: 25751578 [TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial. Schwartz S; Etropolski M; Shapiro DY; Okamoto A; Lange R; Haeussler J; Rauschkolb C Curr Med Res Opin; 2011 Jan; 27(1):151-62. PubMed ID: 21162697 [TBL] [Abstract][Full Text] [Related]
5. Lenalidomide for complex regional pain syndrome type 1: lack of efficacy in a phase II randomized study. Manning DC; Alexander G; Arezzo JC; Cooper A; Harden RN; Oaklander AL; Raja SN; Rauck R; Schwartzman R J Pain; 2014 Dec; 15(12):1366-76. PubMed ID: 25283471 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study. Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106 [TBL] [Abstract][Full Text] [Related]
7. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study. Simpson DM; Messina J; Xie F; Hale M Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282 [TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled, multicenter, repeat-dose study of two intravenous acetaminophen dosing regimens for the treatment of pain after abdominal laparoscopic surgery. Wininger SJ; Miller H; Minkowitz HS; Royal MA; Ang RY; Breitmeyer JB; Singla NK Clin Ther; 2010 Dec; 32(14):2348-69. PubMed ID: 21353105 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of perampanel in patients with drug-resistant partial seizures after conversion from double-blind placebo to open-label perampanel. Montouris G; Yang H; Williams B; Zhou S; Laurenza A; Fain R Epilepsy Res; 2015 Aug; 114():131-40. PubMed ID: 26088896 [TBL] [Abstract][Full Text] [Related]
10. Percutaneous epidural lysis of adhesions in chronic lumbar radicular pain: a randomized, double-blind, placebo-controlled trial. Gerdesmeyer L; Wagenpfeil S; Birkenmaier C; Veihelmann A; Hauschild M; Wagner K; Muderis MA; Gollwitzer H; Diehl P; Toepfer A Pain Physician; 2013; 16(3):185-96. PubMed ID: 23703406 [TBL] [Abstract][Full Text] [Related]
11. Hydromorphone extended release for neuropathic and non-neuropathic/nociceptive chronic low back pain: a post hoc analysis of data from a randomized, multicenter, double-blind, placebo-controlled clinical trial. Nalamachu S; Hale M; Khan A J Opioid Manag; 2014; 10(5):311-22. PubMed ID: 25350473 [TBL] [Abstract][Full Text] [Related]
12. Double-blind, placebo-controlled trial of lamotrigine in combination with other medications for neuropathic pain. Silver M; Blum D; Grainger J; Hammer AE; Quessy S J Pain Symptom Manage; 2007 Oct; 34(4):446-54. PubMed ID: 17662571 [TBL] [Abstract][Full Text] [Related]
13. Analgesic efficacy and safety of the novel p38 MAP kinase inhibitor, losmapimod, in patients with neuropathic pain following peripheral nerve injury: a double-blind, placebo-controlled study. Ostenfeld T; Krishen A; Lai RY; Bullman J; Baines AJ; Green J; Anand P; Kelly M Eur J Pain; 2013 Jul; 17(6):844-57. PubMed ID: 23239139 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648 [TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Dietary Agmatine Sulfate in Lumbar Disc-associated Radiculopathy. An Open-label, Dose-escalating Study Followed by a Randomized, Double-blind, Placebo-controlled Trial. Keynan O; Mirovsky Y; Dekel S; Gilad VH; Gilad GM Pain Med; 2010 Mar; 11(3):356-68. PubMed ID: 20447305 [TBL] [Abstract][Full Text] [Related]
17. Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension. Trenkwalder C; Beneš H; Grote L; García-Borreguero D; Högl B; Hopp M; Bosse B; Oksche A; Reimer K; Winkelmann J; Allen RP; Kohnen R; Lancet Neurol; 2013 Dec; 12(12):1141-50. PubMed ID: 24140442 [TBL] [Abstract][Full Text] [Related]
18. Docetaxel and prednisone with or without lenalidomide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (MAINSAIL): a randomised, double-blind, placebo-controlled phase 3 trial. Petrylak DP; Vogelzang NJ; Budnik N; Wiechno PJ; Sternberg CN; Doner K; Bellmunt J; Burke JM; de Olza MO; Choudhury A; Gschwend JE; Kopyltsov E; Flechon A; Van As N; Houede N; Barton D; Fandi A; Jungnelius U; Li S; de Wit R; Fizazi K Lancet Oncol; 2015 Apr; 16(4):417-25. PubMed ID: 25743937 [TBL] [Abstract][Full Text] [Related]
19. Treatment of patients with diabetic peripheral neuropathic pain in China: a double-blind randomised trial of duloxetine vs. placebo. Gao Y; Guo X; Han P; Li Q; Yang G; Qu S; Yue L; Wang CN; Skljarevski V; Dueñas H; Raskin J; Gu L Int J Clin Pract; 2015 Sep; 69(9):957-66. PubMed ID: 25939897 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China. Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]